Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating)’s share price dropped 4.2% during trading on Friday . The stock traded as low as $22.32 and last traded at $22.40. Approximately 78,499 shares traded hands during trading, a decline of 90% from the average daily volume of 796,915 shares. The stock had previously closed at $23.39. Wall […]
Eversept Partners LP lessened its stake in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) by 53.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 137,423 shares of the company’s stock after selling 156,680 shares during the period. Eversept Partners LP […]
First Light Asset Management LLC increased its holdings in shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) by 9.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 1,057,881 shares of the company’s stock after acquiring an additional 92,767 shares during the quarter. Pliant Therapeutics makes up approximately 1.9% of First Light Asset […]
Tekla Capital Management LLC acquired a new stake in Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 35,233 shares of the company’s stock, valued at approximately $681,000. Tekla Capital Management LLC owned approximately 0.07% of Pliant Therapeutics […]
Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) – Investment analysts at Cantor Fitzgerald issued their FY2023 earnings per share estimates for shares of Pliant Therapeutics in a research report issued on Monday, May 15th. Cantor Fitzgerald analyst P. Stavropoulos expects that the company will post earnings per share of ($2.99) for the year. Cantor Fitzgerald […]